NCT05653882 A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05649618 TIL Cells for the Treatment of the Advanced Solid Tumors Patients Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT05645523 Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT05642780 SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05638828 A Study of RD14-01 in Patients With Advanced Solid Tumors Status UNKNOWN Phase EARLY_PHASE1
NCT05627063 A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05626764 QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management Status UNKNOWN Phase N/A
NCT05585684 Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection Status RECRUITING Phase N/A
NCT05584670 A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05583201 NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT05581719 A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy Status TERMINATED Phase PHASE1/PHASE2
NCT05580991 Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05578092 A Phase 1 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway Status TERMINATED Phase PHASE1
NCT05576961 Safety and Efficacy of RX-af01 Combined With PD-1 Antibody Status RECRUITING Phase PHASE1/PHASE2
NCT05566574 A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05557045 A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 Status RECRUITING Phase PHASE1
NCT05547906 Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT05544552 Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05544240 Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1